Showing results (201-210 of 219) with videos related to
Sort By:
Pageof 22
Gastro Hep Advances|August 12, 2024
Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical TrialYuval Ishay, Joel Neutel, Yotam Kolben, et al.Discoveries (Craiova, Romania)|July 17, 2023
Codivir suppresses SARS-Cov-2 viral replication and stabilizes clinical outcome: In vitro and Phase I clinical trial resultsYotam Kolben, Eynat Finkelshtein, Esmira Naftali, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2004
Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trialEran Israeli, Rifaat Safadi, Alaa Melhem, et al.Journal of Hepatology|March 7, 2006
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSCAlaa Melhem, Nidal Muhanna, Amal Bishara, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 11, 2023
A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trialRam Gelman, Noa Hurvitz, Rima Nesserat, et al.The Journal of Pathology|November 2, 2005
Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levelsEran Elinav, Orit Pappo, Miriam Sklair-Levy, et al.Transplantation|July 9, 2004
Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up studyOren Shibolet, Eran Elinav, Yaron Ilan, et al.The American Journal of Gastroenterology|December 18, 2008
Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in miceYosefa Avraham, Olga Zolotarev, Nikolaos C Grigoriadis, et al.Journal of Clinical Gastroenterology|August 6, 2005
Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trialAlla Melhem, Mirela Stern, Oren Shibolet, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|June 25, 2005
Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytesMaya Margalit, Samir Abu Gazala, Samir Abu Ghazala, et al.Pageof 22